Dr. Michael Irwin, Director and Cousins Distinguished Professor of Psychiatry at UCLA Medical Center, has been recognized as a “Leader in Medicine” among “America’s Best Doctors” for 2017. He will be sharing his knowledge and expertise in the areas of Neuropsychiatry, Psychiatry, and Psychoneuroimmunology.
Dr. Irwin has been active in the healthcare industry for the past 35 years. He obtained his MD from the University of California, San Diego, in 1981, and completed his Residency at the UCLA School of Medicine in 1985. Dr. Irwin’s strong interest in behavioral health led him to his current profession. His day-to-day responsibilities include research regarding how inflammation can affect depression and the regulation of the immune system and oversight of a staff of 50 and a junior staff of 5 direct reports. He is also responsible for over $5 million worth of NIH funding.
Dr. Irwin attributes his success to luck and opportunity, hard work, being intuitive, attending and working for an excellent school, and the amazing support of his family. Among his many accomplishments, he is most proud of those that he has mentored and trained and their great success. He has been published in over 340 research articles, 2 books, and several yearly lectures. His long-term goals include establish primary care models for the underserved.
Dr. Irwin’s many awards and honors include the Early Career Award, American Psychosomatic Society (1991); President, Psychoneuroimmunology Research Society (2001); Member, National Advisory Council, Center for Complementary and Alternative Medicine (2001-2004); President, Academy of Behavioral Medicine Research (2003); Outstanding Faculty Research Mentor Award, UCLA School of Medicine (2005); Norman Cousins Research Award, Psychoneuroimmunology Research Society (2007); Chair, Blue Ribbon Intramural Research Strategic Planning Panel, NCCAM (2008); Distinguished Fellow, American Psychiatric Association (2008); Secretary Treasurer, American Psychosomatic Society (2008-2010); Lauda Wellness Award (2009); President-Elect/President, American Psychosomatic Society (2010-2011); Best Research Prize, European Society of Integrative Medicine (2014); and Chairperson, IH Centers for Scientific Review, Mechanisms of Emotion, Stress and Health Study Section (2014-2016).
Dr. Irwin has received funding awards from the National Institute of Aging, National Cancer Institute, National Heart Lung and Blood Disorders Institute, National Institute of Alcoholism and Alcohol Abuse, National Institute of Arthritis and Musculoskeletal Disorders, National Institute of Drug Abuse, National Center for Complementary and Alternative Medicine (NCCAM), and the National Institute of Mental Health.
Dr. Irwin is proud to have had his research on Meditation published in the Los Angeles Times.
Share this entry
Director and Cousins Distinguished Professor of Psychiatry at UCLA Medical Center
- Dr. Michael’s day to day responsibilities include research regarding how inflammation can affect depression and the regulation of the immune system.
- In addition, he is also responsible for over five-million-dollar worth of NIH funding.
- Among his many accomplishments, he is most proud of those that he has mentored and trained and their great success.
- Dr. Michael is also proud to have been published in over 340 research articles, 2 books, and several yearly lectures.
- Irwin MR, Cole S: Reciprocal regulation of neural and innate immune systems. Nature Reviews Immunology 11:625-32, 2011. PMID: 21818124.
- Slavich G, Irwin MR: From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychological Bulletin. 140(3):774-815, 2014. PMID: 24417575
- Irwin MR: Why sleep is important to health: a psychoneuroimmunology perspective. Annual Review of Psychology 2014 Jul 21. [Epub ahead of print] PMID: 25061767Irwin MR, Cole S: Reciprocal regulation of neural and innate immune systems. Nature Reviews Immunology 11:625-32, 2011. PMID: 21818124.
- Irwin MR, Wang M, Campomayor CO, Collado-Hidalgo A, Cole SW: Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Archives of Internal Medicine 166:1756-1762, 2006. PMID: 16983055
- Black DS, O’Reilly GA, Olmstead R, Breen EC, Irwin MR: Mindfulness meditation improves sleep quality and daytime impairment in older adults with prodromal sleep disturbances: a randomized controlled trial. Journal of the American Medical Association: Internal Medicine. 175(4):494-501, 2015. doi:10.1001/jamainternmed.2014.8081.PMID
- Irwin MR, Olmstead R, Breen EC, Witarama T, Carrillo C, Sadeghi N, Nicassio P, Cole SW: Cognitive behavioral therapy and Tai Chi reverse cellular and genomic markers of inflammation in late life insomnia: a randomized controlled trial. Biological Psychiatry 78(10):721-9, 2015 PMID: 25748580.
- Irwin MR, Olmstead R, Carroll JE: Sleep disturbance, sleep duration, and inflammation: a systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biological Psychiatry 80:40-52, 2016 PMID: 26140821